STRS Ohio’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $784K | Sell |
3,492
-5
| -0.1% | -$1.25K | ﹤0.01% | 801 |
|
|
2025
Q4 | $842K | Sell |
3,497
-30,494
| -90% | -$7.8M | ﹤0.01% | 767 |
|
|
2025
Q3 | $9.3M | Buy |
33,991
+30,501
| +874% | +$8.33M | 0.03% | 417 |
|
|
2025
Q2 | $900K | Buy |
+3,490
| New | +$833K | ﹤0.01% | 960 |
|
|
2025
Q1 | – | Sell |
-21,500
| Closed | -$4.92M | – | 2000 |
|
|
2024
Q4 | $4.92M | Hold |
21,500
| – | – | 0.02% | 494 |
|
|
2024
Q3 | $5.25M | Sell |
21,500
-5,000
| -19% | -$1.12M | 0.02% | 479 |
|
|
2024
Q2 | $5.07M | Hold |
26,500
| – | – | 0.02% | 458 |
|
|
2024
Q1 | $5.25M | Sell |
26,500
-11,000
| -29% | -$2.02M | 0.02% | 465 |
|
|
2023
Q4 | $6.45M | Sell |
37,500
-61,000
| -62% | -$9.37M | 0.03% | 424 |
|
|
2023
Q3 | $14.6M | Hold |
98,500
| – | – | 0.06% | 302 |
|
|
2023
Q2 | $21.5M | Buy |
98,500
+38,500
| +64% | +$8.58M | 0.09% | 245 |
|
|
2023
Q1 | $13.1M | Buy |
60,000
+10,000
| +20% | +$2.17M | 0.06% | 331 |
|
|
2022
Q4 | $10.4M | Hold |
50,000
| – | – | 0.05% | 376 |
|
|
2022
Q3 | $10.9M | Buy |
+50,000
| New | +$11.4M | 0.05% | 348 |
|
|
2022
Q2 | – | Sell |
-6,174
| Closed | -$1.5M | – | 2247 |
|
|
2022
Q1 | $1.5M | Buy |
6,174
+550
| +10% | +$133K | 0.01% | 840 |
|
|
2021
Q4 | $1.46M | Buy |
5,624
+3,042
| +118% | +$789K | 0.01% | 897 |
|
|
2021
Q3 | $680K | Sell |
2,582
-299
| -10% | -$81.8K | ﹤0.01% | 1379 |
|
|
2021
Q2 | $710K | Sell |
2,881
-3,251
| -53% | -$683K | ﹤0.01% | 1429 |
|
|
2021
Q1 | $1.19M | Sell |
6,132
-110
| -2% | -$22.1K | ﹤0.01% | 1041 |
|
|
2020
Q4 | $1.33M | Buy |
6,242
+588
| +10% | +$117K | 0.01% | 902 |
|
|
2020
Q3 | $969K | Sell |
5,654
-1,180
| -17% | -$218K | ﹤0.01% | 946 |
|
|
2020
Q2 | $1.31M | Sell |
6,834
-2,987
| -30% | -$489K | 0.01% | 767 |
|
|
2020
Q1 | $1.45M | Sell |
9,821
-3,533
| -26% | -$563K | 0.01% | 627 |
|
|
2019
Q4 | $2.07M | Buy |
13,354
+8,196
| +159% | +$1.18M | 0.01% | 659 |
|
|
2019
Q3 | $696K | Buy |
5,158
+259
| +5% | +$33.9K | ﹤0.01% | 987 |
|
|
2019
Q2 | $597K | Sell |
4,899
-14,069
| -74% | -$1.56M | ﹤0.01% | 1177 |
|
|
2019
Q1 | $1.97M | Sell |
18,968
-912
| -5% | -$94.1K | 0.01% | 644 |
|
|
2018
Q4 | $2.26M | Sell |
19,880
-3,647
| -16% | -$391K | 0.01% | 600 |
|
|
2018
Q3 | $2.71M | Sell |
23,527
-149
| -0.6% | -$16.3K | 0.01% | 585 |
|
|
2018
Q2 | $2.45M | Sell |
23,676
-511
| -2% | -$51.7K | 0.01% | 605 |
|
|
2018
Q1 | $2.38M | Buy |
24,187
+4,125
| +21% | +$390K | 0.01% | 592 |
|
|
2017
Q4 | $1.7M | Sell |
20,062
-727
| -3% | -$60.1K | 0.01% | 654 |
|
|
2017
Q3 | $1.6M | Sell |
20,789
-647
| -3% | -$49.5K | 0.01% | 679 |
|
|
2017
Q2 | $1.67M | Buy |
21,436
+523
| +3% | +$37.4K | 0.01% | 652 |
|
|
2017
Q1 | $1.5M | Buy |
20,913
+1,240
| +6% | +$85.7K | 0.01% | 690 |
|
|
2016
Q4 | $1.22M | Buy |
19,673
+3,372
| +21% | +$207K | 0.01% | 751 |
|
|
2016
Q3 | $1.06M | Buy |
16,301
+211
| +1% | +$14K | ﹤0.01% | 791 |
|
|
2016
Q2 | $1.02M | Buy |
16,090
+4,162
| +35% | +$245K | ﹤0.01% | 802 |
|
|
2016
Q1 | $689K | Buy |
11,928
+1,183
| +11% | +$67K | ﹤0.01% | 1021 |
|
|
2015
Q4 | $576K | Buy |
10,745
+1,483
| +16% | +$83.6K | ﹤0.01% | 1217 |
|
|
2015
Q3 | $471K | Buy |
9,262
+3,664
| +65% | +$197K | ﹤0.01% | 1304 |
|
|
2015
Q2 | $315K | Buy |
5,598
+3,525
| +170% | +$222K | ﹤0.01% | 1469 |
|
|
2015
Q1 | $148K | Buy |
+2,073
| New | +$135K | ﹤0.01% | 1549 |
|
Other funds holding RMD
VCM
VPM
DAM
STRS Ohio's RMD Position: Q1 2026 in Review
STRS Ohio reduced its ResMed (RMD) stake by 0.14% in Q1 2026, selling an estimated $1.25K and leaving 3,492 shares worth $784K. The position accounts for ﹤0.01% of the portfolio, ranked #801.
STRS Ohio first reported a position in RMD in Q1 2015 and has held it in 43 quarters since. The position peaked at $21.5M in Q2 2023. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- STRS Ohio held 3,492 shares of ResMed worth $784K as of Q1 2026.
- STRS Ohio sold 5 ResMed shares in Q1 2026, an estimated $1.25K.
- ResMed made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #801 holding.
- STRS Ohio first reported a position in ResMed in Q1 2015 and has held it in 43 quarters since.
- STRS Ohio's ResMed position peaked at $21.5M in Q2 2023.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.